Back HIV/AIDS HIV/AIDS Topics HIV Prevention

HIV Risk Behavior Remains Common Among People Who Inject Drugs in U.S.

An analysis from the CDC's National HIV Behavioral Surveillance system found that 11% of injection drug users in 20 U.S. cities were HIV-positive in 2012, according to a report in the March 20 Morbidity and Mortality Weekly Report. One-third of the interviewees reported sharing used injection equipment, putting them at risk for acquiring HIV and hepatitis B and C, while a majority reported sex without condoms.

alt

Read more:

Some Providers Remain Reluctant to Prescribe HIV Pre-Exposure Prophylaxis

Despite a growing body of evidence showing that Truvada (tenofovir/emtricitabine) pre-exposure prophylaxis, or PrEP, is highly effective for HIV prevention, less than half of surveyed healthcare providers are likely to prescribe it for at-risk heterosexuals or people who inject drugs -- though the likelihood approaches 80% for gay men with HIV-positive partners -- according to a study published in the April edition of HIV Specialist, the magazine of the American Academy of HIV Medicine (AAHIVM).

alt

Read more:

CROI 2015: Circumcision is Reducing HIV Incidence in Uganda, Rakai Community Study Shows

The growing uptake of medical male circumcision by men in the Rakai district of Uganda is leading to a substantial reduction in HIV incidence among men in one of the districts worst affected by HIV, Xiangrong Kong of Johns Hopkins Bloomberg School of Public Health reported at the recent 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.

alt

Read more:

Study Suggests HIV May Be Less Infectious than Assumed During Early Infection

The likelihood of HIV transmission during the acute phase of HIV infection may not be as high as previously estimated based on data from a retrospective cohort study in Rakai, Uganda, according to an analysis published in the March 17 edition of PLoS Medicine. If confirmed, these findings suggests that antiretroviral treatment as prevention (TasP) may be even more effective, as it would not be compromised as much by transmission occurring before partners with HIV are diagnosed and start therapy.

alt

Read more:

CROI 2015: PEPFAR Abstinence and Faithfulness Funding Had No Impact on Sexual Behavior in Africa

Nearly $1.3 billion spent on U.S.-funded programs to promote abstinence and faithfulness had no significant impact on sexual behavior in 14 countries in sub-Saharan Africa, an analysis of sexual behavior data has shown. The preliminary findings were presented by Nathan Lo of Stanford University School of Medicine at the recent 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.

alt

Read more: